Amrutanjan Health Care Limited (BOM: 590006)

Amrutanjan Health Care Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	4,377	4,212	3,796	4,058	3,328	2,615
Other Revenue	10.06	1.41	1.23	1.06	1.69	2.72
Revenue	4,387	4,214	3,798	4,059	3,330	2,617
Revenue Growth (YoY)	16.91%	10.96%	-6.45%	21.90%	27.23%	3.24%
Cost of Revenue	2,239	2,170	1,874	1,838	1,432	1,200
Gross Profit	2,148	2,043	1,924	2,221	1,899	1,418
Selling, General & Admin	536.84	484.02	492.2	484.84	420.53	834.18
Other Operating Expenses	1,038	1,026	960	879.76	647.2	272.26
Operating Expenses	1,638	1,571	1,505	1,423	1,181	1,150
Operating Income	509.67	472.47	418.55	798.41	717.93	267.76
Interest Expense	-2.23	-1.57	-0.77	-4.85	-5	-2.21
Interest & Investment Income	148.05	148.05	117.83	111.7	93.88	65.72
Currency Exchange Gain (Loss)	0.62	0.62	2.38	1.25	0.59	1.33
Other Non Operating Income (Expenses)	0.69	0.69	0.24	0.83	0.42	1.31
EBT Excluding Unusual Items	656.8	620.26	538.23	907.34	807.82	333.92
Gain (Loss) on Sale of Investments	-1.26	-1.26	-2.05	-1.57	-3.67	10.62
Gain (Loss) on Sale of Assets	1.57	1.57	0.27	-	0.89	-
Asset Writedown	-1.11	-1.11	-	-	-	-
Pretax Income	656	619.46	536.45	905.77	819.05	344.54
Income Tax Expense	180.8	169.73	138.11	233.88	207.14	93.71
Earnings From Continuing Operations	475.2	449.73	398.35	671.89	611.9	250.83
Net Income	475.2	449.73	398.35	671.89	611.9	250.83
Net Income to Common	475.2	449.73	398.35	671.89	611.9	250.83
Net Income Growth	27.50%	12.90%	-40.71%	9.80%	143.95%	2.32%
Shares Outstanding (Basic)	29	29	29	29	29	29
Shares Outstanding (Diluted)	29	29	29	29	29	29
Shares Change (YoY)	-0.72%	-0.71%	-0.03%	0.00%	0.02%	-0.00%
EPS (Basic)	16.42	15.50	13.65	23.00	20.94	8.58
EPS (Diluted)	16.42	15.50	13.63	22.98	20.93	8.58
EPS Growth	28.42%	13.70%	-40.69%	9.79%	143.94%	2.31%
Free Cash Flow	181.38	211.93	112.54	287.32	889.09	156.32
Free Cash Flow Per Share	6.27	7.30	3.85	9.83	30.41	5.35
Dividend Per Share	3.600	4.600	4.600	4.600	4.200	1.100
Dividend Growth	-21.74%	0%	0%	9.52%	281.82%	-48.84%
Gross Margin	48.96%	48.49%	50.65%	54.72%	57.01%	54.17%
Operating Margin	11.62%	11.21%	11.02%	19.67%	21.56%	10.23%
Profit Margin	10.83%	10.67%	10.49%	16.55%	18.37%	9.58%
Free Cash Flow Margin	4.13%	5.03%	2.96%	7.08%	26.70%	5.97%
EBITDA	560.47	520.33	458.66	830.49	747.3	304.87
EBITDA Margin	12.78%	12.35%	12.08%	20.46%	22.44%	11.65%
D&A For EBITDA	50.8	47.86	40.11	32.09	29.37	37.12
EBIT	509.67	472.47	418.55	798.41	717.93	267.76
EBIT Margin	11.62%	11.21%	11.02%	19.67%	21.56%	10.23%
Effective Tax Rate	27.56%	27.40%	25.74%	25.82%	25.29%	27.20%
Revenue as Reported	4,549	4,376	3,942	4,212	3,442	2,698
Advertising Expenses	-	-	-	-	-	435.05

Source: S&P Capital IQ. Standard template. Financial Sources.